Is Keflex (cephalexin) a beta-lactam antibiotic?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Keflex a Beta-Lactam Antibiotic?

Yes, Keflex (cephalexin) is definitively a beta-lactam antibiotic—specifically, it is a first-generation cephalosporin that contains the characteristic beta-lactam ring structure shared by all cephalosporins and penicillins. 1, 2

Structural Classification

  • Cephalexin belongs to the beta-lactam class of antimicrobials, which are characterized by the presence of a beta-lactam ring in their molecular structure 1
  • The beta-lactam ring (shown in green in structural diagrams) is the core structural feature that cephalexin shares with penicillins, though the two drug classes differ in their bicyclic ring systems 1
  • Cephalexin is specifically classified as a first-generation cephalosporin, distinct from aminopenicillins like amoxicillin or penicillinase-resistant penicillins like cloxacillin 3

Mechanism of Action

  • Beta-lactam antibiotics, including cephalexin, exert their antibacterial effect by inhibiting bacterial cell-wall synthesis and producing autolysis 1
  • This action occurs through binding to penicillin-binding proteins (PBPs) in the bacterial cell wall 1

Clinical Implications of Beta-Lactam Structure

Cross-Reactivity Considerations

  • The FDA label explicitly warns that cross-hypersensitivity among beta-lactam antibiotics has been clearly documented and may occur in up to 10% of patients with a history of penicillin allergy 2
  • However, more recent evidence shows the actual cross-reactivity rate is much lower—approximately 2-4.8% in patients with confirmed penicillin allergy 3
  • Cross-reactivity is primarily determined by similarity of the R1 side chain structure, not the beta-lactam ring itself 1
  • Cephalexin shares an identical R1 side chain with amoxicillin and ampicillin, which increases the theoretical risk of cross-reactivity between these specific agents 1, 3

Allergy Management

  • For patients with a history of non-anaphylactic penicillin allergy, cephalosporins with dissimilar R1 side chains can be administered by direct drug challenge without prior testing 1
  • However, because cephalexin shares the R1 side chain with amoxicillin/ampicillin, it falls into the higher cross-reactivity category (16.45% skin test positivity in proven aminopenicillin allergy) 1
  • This recommendation does NOT apply to severe delayed reactions such as Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, drug-induced liver injury, or acute interstitial nephritis 4

Chemical Structure Details

  • The FDA label describes cephalexin as 7-(D-α-amino-α-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid, monohydrate 2
  • Cephalexin has a D-phenylglycyl group as substituent at the 7-amino position and an unsubstituted methyl group at the 3-position 2
  • The compound exists as a zwitterion (containing both basic and acidic groups) with an isoelectric point of approximately 4.5 to 5 2

Antimicrobial Spectrum

  • As a beta-lactam antibiotic, cephalexin has an antimicrobial spectrum that includes pathogens most frequently encountered in clinical practice, particularly gram-positive cocci 5
  • It is useful for infections of the upper and lower respiratory tract, skin and soft tissue, and genitourinary tract 5
  • A significant limitation is that cephalexin has poor activity against Haemophilus influenzae, which reduces its utility in pediatric respiratory infections and some cases of acute exacerbations of chronic bronchitis 6, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Classification and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cefuroxime Administration in Patients with Amoxicillin Allergy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Research

Cephalexin in lower respiratory tract infections.

Postgraduate medical journal, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.